Bli medlem
Bli medlem

Du är här


Great success for the Invest Securities BioMed Event® : over 300 participants for this first edition

Great success for the « Invest Securities BioMed Event® »

The "Invest Securities BioMed Event®", launched by Invest Securities last
Wednesday, January 27 was greatly successful with over 300 business managers
and investors throughout the day.

Organized by CF&B Communication, the event gathered 60 European listed and
non-listed companies (French, Swiss, Dutch, Belgian, Spanish.), from the
sectors of biotechs, health services, pharmaceuticals and medical techs, who
met 135 investors, Fund Managers, Family offices, Private Equity funds.
The day was busy in presentations and exchanges about these companies'
development, challenges and the financing of their growth. In particular,
over 600 individual meetings with investors were organized.
The first edition of the « Invest Securities BioMed Event® » has demonstrated
Invest Securities' expertise in the field of Life Science that is now
supported by a dedicated team of 6 experts, analysts and investment bankers.
Over the past months, they have assisted many business from the sectors in
their equity capital operations, such as Biophytis, OSE Pharma, Quantum
Genomics, Safe Orthopaedics.
Jean-Emmanuel Vernay, Managing Director, Invest Securities, states:
"We were really pleased to welcome so many quality companies and to allow for
such proximity for them with investors. Communications between players are
all the more important nowadays on ever more complex markets. The BioMed
Event has become the greatest pan-European event dedicated to Biotechs'
financing and we are already thinking of a 2nd edition."
Francis Bader, Chairman, CF&B Communication adds:
« We were happy to work again with Invest Securities, and their involvement in
the making of the event has been the key to its success. By combining Invest
Securities' expertise in Life Science sectors together with CF&B
Communication's know-how in designing and producing operations dedicated to
the financial industry, we have together managed to make the best of the
"Invest Securities BioMed Event®", that is already a major pan-European
About Invest Securities (
Invest Securities is an independant financial services group of more than 90
people, created in 2001 that provides full investment banking services
through three specialized entities : Invest Securities Corporate ( Corporate
finance), Invest Securities société de bourse (an investment services
provider approved by Banque de France), Amplégest ( an independent asset
management company , oversee 1 Billion Euros of assets). A sum of combined
skills allowing to handle any type of long term financing operations (M&A,
private equity, equity capital markets).
More than 170 deals since its creation ( Ipo,Public offerings, private
placements, trade sales, mergers.). 1st underwriter on the Euronext Paris and
Brussels market with 50 IPO's. A high value-added services full broker (
analysis, intermediation, execution), a full range of services for issuers (
corporate broking, liquidity providing, financial analysis, buy-backs, tender
offers, roadshows, sales&trading, primary market .) . An independent asset
management company ( 610 M€ under asset) founded in 2007 with Invest
Securities. A team of 22 people with strong values.
About CF&B Communication (
Specialized in the organization of meetings between listed companies and
institutional investors for 17 years in Europe, CF&B Communication holds over
18 events per year in partnership with Stock Exchanges, Brokers, Banks,
communications agencies, etc.
For further queries, please contact Thierry
ROUSSILHEtroussilhe@invest-securities.comor Caroline


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: CF&B Communication via Globenewswire


Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.